DrugPatentWatch Database Preview
Details for Patent: 7,309,707
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which drugs does patent 7,309,707 protect, and when does it expire?
Patent 7,309,707 protects SPIRIVA and is included in one NDA.
Protection for SPIRIVA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has fifty-six patent family members in thirty-seven countries.
Summary for Patent: 7,309,707
| Title: | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| Abstract: | The invention relates to a crystalline micronisate of (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-7-[(hydroxydi-2-thienylacetyl- )oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0.sup.2,4]nonane-bromide, processes for preparing it and its use for preparing a pharmaceutical composition, particularly for preparing a pharmaceutical composition with an anticholinergic activity. |
| Inventor(s): | Bender; Helmut (Wiesbaden, DE), Graebner; Hagen (Ingelheim, DE), Schindler; Konrad (Ingelheim, DE), Trunk; Michael (Ingelheim, DE), Walz; Michael (Bingen, DE) |
| Assignee: | Boehringer Ingelheim Pharma GmbH & Co. KG (Ingelheim, DE) |
| Application Number: | 10/385,175 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,309,707 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Process; Device; |
Drugs Protected by US Patent 7,309,707
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | SPIRIVA | tiotropium bromide | POWDER;INHALATION | 021395-001 | Jan 30, 2004 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,309,707
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 102 12 264 | Mar 20, 2002 |
International Family Members for US Patent 7,309,707
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039017 | Start Trial | |||
| Austria | 369365 | Start Trial | |||
| Australia | 2003212327 | Start Trial | |||
| Brazil | 0308513 | Start Trial | |||
| Brazil | PI0308513 | Start Trial | |||
| Canada | 2479652 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
